Direkt zum Inhalt
Merck

15522

D-(+)-Galactose

meets analytical specification of Ph. Eur., BP

Synonym(e):

Galactose

Slide 1 of 1
Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Preise und Verfügbarkeit sind derzeit nicht verfügbar.

Über diesen Artikel

Empirische Formel (Hill-System):
C6H12O6
CAS-Nummer:
59-23-4
Molekulargewicht:
180.16
UNSPSC Code:
12352201
NACRES:
NA.21
PubChem Substance ID:
57647466
EC Number:
200-416-4
Beilstein/REAXYS Number:
1724619
MDL number:
MFCD00151230

Wichtige Dokumente

Gesamtdokumentation anzeigen

Fortfahren mit

Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten

form

powder

Quality Level

200

quality

meets analytical specification of Ph. Eur., BP

technique(s)

IR spectroscopy: suitable

impurities

acid. or alk. react. impurities, in accordance, microbiological impurity, in accordance, residual solvents, in accordance, ≤1.0% water (Karl Fischer)

color

white

useful pH range

5.0-7.0 (25 °C, 180 g/L)

mp

168-170 °C (lit.)

solubility

H2O: soluble 180 g/L at 20 °C

suitability

in accordance for appearance of solution, in accordance for identity (IR)

application(s)

pharmaceutical (small molecule)

SMILES string

OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O

InChI

1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5+,6-/m0/s1

InChI key

GZCGUPFRVQAUEE-KCDKBNATSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 4

Dieser Artikel
48260G0625G6404
D-(+)-Galactose meets analytical specification of Ph. Eur., BP

Sigma-Aldrich

15522

D-(+)-Galactose

D-(+)-Galactose suitable for microbiology, ≥99.0%

Millipore

48260

D-(+)-Galactose

D-(+)-Galactose ≥98% (HPLC)

Sigma-Aldrich

G0625

D-(+)-Galactose

D-(+)-Galactose BioXtra, ≥99% (HPLC)

Sigma-Aldrich

G6404

D-(+)-Galactose

technique(s)

IR spectroscopy: suitable

technique(s)

-

technique(s)

HPLC: suitable, cell based assay: suitable

technique(s)

HPLC: suitable

Quality Level

200

Quality Level

200

Quality Level

300

Quality Level

200

solubility

H2O: soluble 180 g/L at 20 °C

solubility

H2O: 0.1 g/mL, clear, colorless

solubility

water: 180 g/L at 20 °C (68 °F )

solubility

H2O: 1 M, clear, colorless

form

powder

form

powder

form

powder

form

powder

suitability

in accordance for appearance of solution, in accordance for identity (IR)

suitability

-

suitability

-

suitability

-

impurities

acid. or alk. react. impurities, in accordance, residual solvents, in accordance, microbiological impurity, in accordance, ≤1.0% water (Karl Fischer)

impurities

-

impurities

-

impurities

≤0.005% Phosphorus (P), ≤0.1% Insoluble matter

Application

D-(+)-Galactose was used for examining the specificity of staining with SBA-FITC during labeling of cells for fluorescence-activated cell sorting (FACS).[1] It was used for selecting the transformed strains of S. cerevisiae.[2]

Biochem/physiol Actions

Galactose is a monosaccharide sugar and is the natural antigen present on the blood cells. It induces memory loss, neurodegeneration as well as oxidative damage in mice due to systemic exposure.[3]
Galactose is a simple monosaccharide that serves as an energy source and as an essential component of glycolipids and glycoproteins. Galactose contributes to energy metabolism via its conversion to glucose by the enzymes that constitute the Leloir pathway. Defects in the genes encoding these proteins lead to the metabolic disorder galactosemia.

Other Notes

To gain a comprehensive understanding of our extensive range of Monosaccharides for your research, we encourage you to visit our Carbohydrates Category page.

Lagerklasse

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number
BCCJ4497
BCCG8311
BCCF3056
BCCD1181
BCBS5475

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Suche nach COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

P J Simmons et al.
Blood, 78(11), 2848-2853 (1991-12-01)
Normal bone marrow cells were isolated by fluorescence-activated cell sorting (FACS) on the basis of CD34 antigen expression and then assayed in vitro for colonies of fibroblastic cells (fibroblast colony-forming units [CFU-F]). Greater than 95% of detectable CFU-F were recovered
Elizabeth M Prescott et al.
Proceedings of the National Academy of Sciences of the United States of America, 99(13), 8796-8801 (2002-06-22)
Transcriptional interference between genes and the regulatory elements of simple eukaryotes such as Saccharomyces cerevisiae is an unavoidable consequence of their compressed genetic arrangement. We have shown previously that with the tandem arranged genes GAL10 and GAL7, inefficient transcriptional termination
Xu Cui et al.
Journal of neuroscience research, 84(3), 647-654 (2006-05-20)
Chronic systemic exposure of mice, rats, and Drosophila to D-galactose causes the acceleration of senescence and has been used as an aging model. The underlying mechanism is yet unclear. To investigate the mechanisms of neurodegeneration in this model, we studied
Michelle P Christie et al.
PloS one, 9(4), e95024-e95024 (2014-04-17)
Glycosylation of biopharmaceuticals can mediate cell specific delivery by targeting carbohydrate receptors. Additionally, glycosylation can improve the physico-chemical (drug-like) properties of peptide based drug candidates. The main purpose of this study was to examine if glycosylation of the peptide enkephalin
Lu Han et al.
Biomaterials, 44, 111-121 (2015-01-27)
Multifunctional nanocomplexes (NCs) consisting of urocanic acid-modified galactosylated trimethyl chitosan (UA-GT) conjugates as polymeric vectors, poly(allylamine hydrochloride)-citraconic anhydride (PAH-Cit) as charge-reversible crosslinkers, and vascular endothelial growth factor (VEGF) siRNA as therapeutic genes, were rationally designed to simultaneously overcome the extracellular
Alle zugehörigen Dokumente anzeigen

Global Trade Item Number

SKUGTIN
N7632-500MG04061837841248
N7632-1G04061834118114
15522-100G-R04061833380505
15522-250G-R04061833440018

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung